# Armodafinil in Binge Eating Disorder (BED)

> **NCT01010789** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 60 (actual)

## Conditions studied

- Binge Eating Disorder
- Overweight
- Obese

## Interventions

- **DRUG:** Armodafinil
- **DRUG:** Armodafinil
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT01010789
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2014-11
- **Final completion:** 2015-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010789, "Armodafinil in Binge Eating Disorder (BED)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01010789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*